Tricyclodecenyl propionate
Common Name: |
Tricyclodecenyl propionate |
IUPAC Name: |
8-tricyclo[5.2.1.02,6]dec-3-enyl propanoate |
Molecular Formula: |
C13H18O2 |
SMILES: |
CCC(=O)OC1CC2CC1C3C2C=CC3 |
Inchi: |
1S/C13H18O2/c1-2-13(14)15-12-7-8-6-11(12)10-5-3-4-9(8)10/h3-4,8-12H,2,5-7H2,1H3 |
Inchi Key: |
BLBJUGKATXCWET-UHFFFAOYSA-N |
Cas No: |
17511-60-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
206.28 |
Mass (g/mol) |
206.131 |
Molar Refractivity |
59.07 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
3 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
276.15 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.77 |
LogP |
2.54 |
iLOGP |
2.85 |
XLOGP3 |
2.63 |
WLOGP |
2.54 |
MLOGP |
2.92 |
ESOL Log S |
-2.58 |
ESOL Solubility (mg/ml) |
0.545 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.83 |
Ali Solubility (mg/ml) |
0.3 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.51 |
Silicos-IT Solubility (mg/ml) |
6.3 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.69 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.535 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.984 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |